Bank of America’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.1K | Buy |
|
|||||
|
2025
Q1 | $37.6K | Sell |
|
|||||
|
2024
Q4 | $83.9K | Buy |
|
|||||
|
2024
Q3 | $62K | Sell |
|
|||||
|
2024
Q2 | $59.3K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $10.8K | Sell |
|
|||||
|
2023
Q2 | $17K | Buy |
|
|||||
|
2023
Q1 | $6.65K | Sell |
|
|||||
|
2022
Q4 | $11.9K | Buy |
|
|||||
|
2022
Q3 | $11K | Hold |
|
|||||
|
2022
Q2 | $40K | Sell |
|
|||||
|
2022
Q1 | $16K | Sell |
|
|||||
|
2021
Q4 | $23K | Sell |
|
|||||
|
2021
Q3 | $107K | Sell |
|
|||||
|
2021
Q2 | $134K | Sell |
|
|||||
|
2021
Q1 | $306K | Buy |
|
|||||
|
2020
Q4 | $171K | Sell |
|
|||||
|
2020
Q3 | $116K | Buy |
|
|||||
|
2020
Q2 | $112K | Sell |
|
|||||
|
2020
Q1 | $108K | Buy |
|
|||||
|
2019
Q4 | $0 | Sell |
|
|||||
|
2019
Q3 | $0 | Sell |
|
|||||
|
2019
Q2 | $77K | Sell |
|
|||||
|
2019
Q1 | $1.52M | Buy |
|
|||||
|
2018
Q4 | $462K | Buy |
|
|||||
|
2018
Q3 | $52K | Buy |
|
|||||
|
2018
Q2 | $41K | Buy |
|
|||||
|
2018
Q1 | $59K | Buy |
|
|||||
|
2017
Q4 | $0 | Hold |
|
|||||
|
2017
Q3 | $0 | Hold |
|
|||||
|
2017
Q2 | $0 | Hold |
|
|||||
|
2017
Q1 | $0 | Sell |
|
|||||
|
2016
Q4 | $0 | Sell |
|
|||||
|
2016
Q3 | $2K | Buy |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2016
Q1 | – | Hold |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $26K | Sell |
|
|||||
|
2015
Q2 | $110K | Buy |
|
|||||
|
2015
Q1 | $110K | Hold |
|
|||||
|
2014
Q4 | $97K | Hold |
|
|||||
|
2014
Q3 | $94K | Sell |
|
|||||
|
2014
Q2 | $422K | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $33K | Sell |
|
|||||
|
2013
Q3 | $51K | Sell |
|
|||||
|
2013
Q2 | $53K | Buy |
|